Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)
Not available.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-02-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11935 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1825208847560605696 |
|---|---|
| author | Sarah Bertoli Emilie Bérard Pierre Peterlin Romain Guieze Yohan Desbrosses Yosr Hicheri Omar Benbrahim Martin Carre Corentin Orvain Anne Banos Marc Bernard Emmanuel Gyan Alain Saad Safia Chebrek Gabrielle Roth Guepin Veronique Dorvaux Laurence Sanhes Maria Pilar Gallego-Hernanz Carole Exbrayat Laure Vincent Chantal Himberlin Célestine Simand Norbert Vey Cindy Fenoll Ariane Mineur Anne Huynh Francois Vergez Isabelle Luquet Laetitia Largeaud Eric Delabesse Arnaud Pigneux Christian Récher French Innovative Leukemia Organization FILO |
| author_facet | Sarah Bertoli Emilie Bérard Pierre Peterlin Romain Guieze Yohan Desbrosses Yosr Hicheri Omar Benbrahim Martin Carre Corentin Orvain Anne Banos Marc Bernard Emmanuel Gyan Alain Saad Safia Chebrek Gabrielle Roth Guepin Veronique Dorvaux Laurence Sanhes Maria Pilar Gallego-Hernanz Carole Exbrayat Laure Vincent Chantal Himberlin Célestine Simand Norbert Vey Cindy Fenoll Ariane Mineur Anne Huynh Francois Vergez Isabelle Luquet Laetitia Largeaud Eric Delabesse Arnaud Pigneux Christian Récher French Innovative Leukemia Organization FILO |
| author_sort | Sarah Bertoli |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-43ab344f899c4878a7ceaf3607bd9e83 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-43ab344f899c4878a7ceaf3607bd9e832025-02-06T19:45:00ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-02-01999110.3324/haematol.2024.286807Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)Sarah Bertoli0Emilie Bérard1Pierre Peterlin2Romain Guieze3Yohan Desbrosses4Yosr Hicheri5Omar Benbrahim6Martin Carre7Corentin Orvain8Anne Banos9Marc Bernard10Emmanuel Gyan11Alain Saad12Safia Chebrek13Gabrielle Roth Guepin14Veronique Dorvaux15Laurence Sanhes16Maria Pilar Gallego-Hernanz17Carole Exbrayat18Laure Vincent19Chantal Himberlin20Célestine Simand21Norbert Vey22Cindy Fenoll23Ariane Mineur24Anne Huynh25Francois Vergez26Isabelle Luquet27Laetitia Largeaud28Eric Delabesse29Arnaud Pigneux30Christian Récher31French Innovative Leukemia Organization FILOService d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, ToulouseService d’Epidémiologie, Centre Hospitalier Universitaire de Toulouse, CERPOP, Inserm, Université Toulouse III Paul Sabatier, ToulouseService d’Hématologie, Centre Hospitalier Universitaire de NantesService d'Hématologie clinique et de thérapie cellulaire, Centre Hospitalier Universitaire de Clermont-FerrandService d’Hématologie, Centre Hospitalier Universitaire de BesançonDépartement d’Hématologie, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, MarseilleService d’Hématologie, Centre Hospitalier d’OrléansService d’Hématologie, Centre Hospitalier Universitaire de GrenobleMaladies du Sang, CHU d’Angers, Fédération Hospitalo-Universitaire Grand-Ouest Acute Leukemia, FHU-GOAL, Université d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Université, CRCI2NA, AngersService d’Hématologie, Centre Hospitalier de la Côte Basque, BayonneService d’Hématologie, Centre Hospitalier Universitaire de RennesService d’Hématologie, Centre Hospitalier Universitaire de ToursService d’Hématologie, Centre Hospitalier de BéziersService d’Onco-Hématologie, Centre Hospitalier d’AvignonService d’Hématologie, Centre Hospitalier Universitaire de NancyService d’Hématologie, Centre Hospitalier de MetzService d’Hématologie, Centre Hospitalier de PerpignanService d’Hématologie, Centre Hospitalier Universitaire de PoitiersService d’Hématologie, Clinique du Parc, Castelnau-le-LezService d’Hématologie, Centre Hospitalier Universitaire de MontpellierService d’Hématologie, Centre Hospitalier Universitaire de ReimsService d’Hématologie, Centre Hospitalier Universitaire de StrasbourgDépartement d’Hématologie, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, MarseilleFrench Innovative Leukemia Organisation, Hôpital Bretonneau, ToursFrench Innovative Leukemia Organisation, Hôpital Bretonneau, ToursService d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, ToulouseLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, ToulouseLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, ToulouseLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, ToulouseLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, ToulouseService d'Hématologie Clinique et de Thérapie Cellulaire, Centre Hospitalier Universitaire de BordeauxService d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse Not available. https://haematologica.org/article/view/11935 |
| spellingShingle | Sarah Bertoli Emilie Bérard Pierre Peterlin Romain Guieze Yohan Desbrosses Yosr Hicheri Omar Benbrahim Martin Carre Corentin Orvain Anne Banos Marc Bernard Emmanuel Gyan Alain Saad Safia Chebrek Gabrielle Roth Guepin Veronique Dorvaux Laurence Sanhes Maria Pilar Gallego-Hernanz Carole Exbrayat Laure Vincent Chantal Himberlin Célestine Simand Norbert Vey Cindy Fenoll Ariane Mineur Anne Huynh Francois Vergez Isabelle Luquet Laetitia Largeaud Eric Delabesse Arnaud Pigneux Christian Récher French Innovative Leukemia Organization FILO Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02) Haematologica |
| title | Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02) |
| title_full | Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02) |
| title_fullStr | Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02) |
| title_full_unstemmed | Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02) |
| title_short | Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02) |
| title_sort | dexamethasone added to induction and post remission therapy in older patients with newly diagnosed acute myeloid leukemia a multicenter phase ii trial dexaml 02 |
| url | https://haematologica.org/article/view/11935 |
| work_keys_str_mv | AT sarahbertoli dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT emilieberard dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT pierrepeterlin dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT romainguieze dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT yohandesbrosses dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT yosrhicheri dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT omarbenbrahim dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT martincarre dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT corentinorvain dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT annebanos dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT marcbernard dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT emmanuelgyan dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT alainsaad dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT safiachebrek dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT gabriellerothguepin dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT veroniquedorvaux dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT laurencesanhes dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT mariapilargallegohernanz dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT caroleexbrayat dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT laurevincent dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT chantalhimberlin dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT celestinesimand dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT norbertvey dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT cindyfenoll dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT arianemineur dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT annehuynh dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT francoisvergez dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT isabelleluquet dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT laetitialargeaud dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT ericdelabesse dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT arnaudpigneux dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT christianrecher dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 AT frenchinnovativeleukemiaorganizationfilo dexamethasoneaddedtoinductionandpostremissiontherapyinolderpatientswithnewlydiagnosedacutemyeloidleukemiaamulticenterphaseiitrialdexaml02 |